News

Mylan‘s Alfuzosin Hydrochloride Extended-release Tablets, 10mg are generic equivalent to Uroxatral, indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. Uroxatral belongs to a group

Avanir alleged that Par’s and Actavis’ proposed generic products infringe certain patents held by the company. The law suit was filed based on the response to abbreviated new

ChromaDex’s net loss was $1.84m, compared to $303,529 for the same period in the prior year. The company’s operating loss was $1.83m for the second quarter ended July

Earlier, the FDA had requested the company to organize two clinical trials – in patients with type 1 diabetes and type 2 diabetes, with the company’s next-generation inhaler.

In the pre-IND meeting, Advaxis has discussed its development plan for ADXS-PSA with the FDA. Based on FDA input, the planned toxicology studies will be completed on schedule

Anda distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines. Anda Distribution executive vice president and COO Albert Paonessa said they look forward to being a

American Pacific’s net loss was $6.16m or $0.82 loss per diluted share, as compared to net loss of $4.57m or $0.61 loss per for the same period in

The company’s loss from operations for the second quarter of 2011 was $2.22m, compared to $2.05m for the same period in 2010. For the six months ended 30

Levadex is an orally inhaled investigational drug which is used for acute treatment of migraine in adults that targets the pharmacokinetic profiles as described in the patent. MAP